4//SEC Filing
Conway Kevin John 4
Accession 0002051408-26-000002
CIK 0001733294other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 4:05 PM ET
Size
8.5 KB
Accession
0002051408-26-000002
Insider Transaction Report
Form 4
Conway Kevin John
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-01-15+59→ 1,926 total - Tax Payment
Common Stock
2026-01-15$5.64/sh−17$96→ 1,909 total - Exercise/Conversion
Restricted Stock Units
[F1][F2]2026-01-15−59→ 235 total→ Common Stock (59 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the right to receive one share of the company's common stock.
- [F2]The grant of 9,390 restricted stock units was made on January 20, 2023. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.
Signature
/s/ Shawna-Gay White, Attorney-in-Fact|2026-01-16
Documents
Issuer
Generation Bio Co.
CIK 0001733294
Entity typeother
Related Parties
1- filerCIK 0002051408
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 4:05 PM ET
- Size
- 8.5 KB